Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
clinical trials
fda
4
×
life sciences
national blog main
boston top stories
deals
investing
drug delivery
medical device
san diego blog main
san francisco blog main
startups
480 biomedical
akouos
arrowmark partners
arsenal medical
astellas pharmaceuticals
beta bionics
bigfoot biomedical
biotech ipos
bob langer
boston university
california institute for biomedical research
chronic rhinosinusitis
congenital hyperinsulinism
covid-19
decibel therapeutics
dexcom
diabetes
dyne therapeutics
edward damiano
eli lilly
eventide asset management
frequency therapeutics
genzyme
george whitesides
harvard university
What
developing
4
×
ipo
million
therapeutics
company
drug
medicines
raised
tests
treat
affects
americans
approved
beta
bionics
biotech
blood
brings
closed
date
debut
device
diabetes
disorders
driven
dyne
dyne’s
fda
frequency
genetic
heads
hearing
key
late
levels
loss
lyra
manages
markets
medical
Language
unset
Current search:
developing
×
fda
×
boston
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests